Obesity Clinical Trials in Los Angeles

Showing 61-80 of 154 trials

Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo

NCT05949008

Metformin is a drug used to treat patients with diabetes. The aim of this study is to examine the effect of Metformin along with a low-calorie diet on obese and/or overweight adults with an increased waist measurement. In addition, the study also aims to look at the effect of the drug vs. placebo on quality of life and physical activity.

NIDDMObesity

University of California, Los Angeles150 participantsStarted Nov 2023

Los Angeles, California, United States

COMPLETED< 1 mile

Pediatric Obesity Weight Evaluation Registry (POWER) Study

NCT02121132

The main objective of this study is to establish a national pediatric obesity registry known as POWER (Pediatric Obesity Weight Evaluation Registry). This registry will contain clinical data from individual comprehensive pediatric weight management programs around the United States for overweight and obese youth.

OverweightObesity

Children's Hospital Medical Center, Cincinnati4,276 participantsStarted May 2014

Cottonwood, Arizona, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +35 more locations

Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo

Pediatric Obesity Weight Evaluation Registry (POWER) Study

Obesity Trials in Other Cities

The Effects of Natural Sugars in Breast Milk on Healthy Infant Growth and Development

Family Intervention to Prevent Childhood Obesity

Enhancing BodyWorks: a Canine Health Literacy Module

In-home Obesity Prevention to Reach Low-income Infants

Early vs. Late Time-Restricted Eating in Adolescents With Obesity (EL TREA)

A Mobile Phone Based Pilot Intervention to Prevent Obesity in Latino Preschool Children

Benefits of Endoscopic Bariatric Procedures

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss

El Sendero: Pathways to Health Study

A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program

Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions

Cardiovascular Risk Screening and Risk Reduction in Women Vets

Gastrointestinal Hormonal Regulation of Obesity

A Single-Group Study to Examine the Efficacy of a Gut Health Supplement to Increase Metabolism, Improve Gut Health, and Support Weight Management

Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants

Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity

Open-Label Study of Setmelanotide in Hypothalamic Obesity

The EMBER Trial for Weight Management Engagement

Other Conditions in Los Angeles